StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research note released on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded Ayala Pharmaceuticals from a neutral rating to a buy rating in a report on Tuesday, May 30th. Ayala Pharmaceuticals […]